# A 10-week Study Evaluating the Efficacy and Safety of PD 0332334 in Patients With Generalized Anxiety Disorder (1)

> **NCT00658008** · PHASE3 · TERMINATED · sponsor: **Pfizer** · enrollment: 501 (actual)

## Conditions studied

- Generalized Anxiety Disorder

## Interventions

- **DRUG:** PD 0332334
- **DRUG:** PD 0332334
- **DRUG:** PD 0332334
- **DRUG:** Paroxetine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00658008
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2008-04
- **Primary completion:** 2009-03
- **Final completion:** 2009-03
- **Target enrollment:** 501 (ACTUAL)
- **Why stopped:** Please see Detailed Description for termination reason.
- **Last updated:** 2012-11-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00658008

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00658008, "A 10-week Study Evaluating the Efficacy and Safety of PD 0332334 in Patients With Generalized Anxiety Disorder (1)". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00658008. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*